COVID-19 Vaccine

Moscow: The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, today announced that the cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, which is…

New Delhi: Prime Minister Narendra Modi chaired a high-level meeting with Chief Ministers of all States and UTs on Tuesday via video conferencing, to review the status and preparedness of COVID-19 response and management, with special…

ନୂଆଦିଲ୍ଲୀ- ଦେଶରେ କୋରୋନା ପରିସ୍ଥିତି ଓ ଟିକା ବିତରଣ ନେଇ ପ୍ରଧାନମନ୍ତ୍ରୀ ନରେନ୍ଦ୍ର ମୋଦି ସବୁ ରାଜ୍ୟର ମୁଖ୍ୟମନ୍ତ୍ରୀଙ୍କ ସହ ଆଜି ଭଚ୍‌ୁର୍ଆଲ ଆଲୋଚନା କରିଛନ୍ତି । ପ୍ରଧାନମନ୍ତ୍ରୀ କହିଛନ୍ତି ଯେ, କେନ୍ଦ୍ର ସରକାର ପରୀକ୍ଷଣର ବିଭିନ୍ନ ପର୍ଯ୍ୟାୟରେ ଥିବା ସବୁ ଟିକା ଉପରେ ନଜର…

ଲଣ୍ଡନ - ଆଷ୍ଟ୍ରାଜେନେକା ପିଏଲସି  ସହଭାଗିତାରେ କରୋନା ଟିକା ବିକଶିତ କରୁଥିବା ଅକ୍ସଫୋର୍ଡ ୟୁନିଭରସିଟି ଏକ ବଡ଼ ସଫଳତା ପାଇଛି । ଅକ୍ସଫୋର୍ଡ ୟୁନିଭରସିଟି ଦାବି କରିଛି ଯେ ପରୀକ୍ଷାରେ ବୟସ୍କ ବ୍ୟକ୍ତିଙ୍କ ଚିକିତ୍ସାରେ ଏହାର ଟିକା ଫଳପ୍ରଦ ସାବ୍ୟସ୍ତ ହୋଇଛି। ଏହି ଟିକା ୫୬-୬୯ ବର୍ଷର…

ନୂଆଦିଲ୍ଲୀ - ଭାରତର ଟିକା ଉତ୍ପାଦନକାରୀ କଂପାନି ସିରମ ଇନଷ୍ଟିଚ୍ୟୁଟର ସିଇଓ ଆଦର ପୁନାୱାଲା କହିଛନ୍ତି ଯେ, ଅକ୍ସଫୋର୍ଡ କୋରୋନା ଟିକାର ଚୂଡାନ୍ତ ପରୀକ୍ଷଣ ଯଦି ସଫଳ ହୁଏ ଓ ରେଗୁଲେଟରୀ ଅନୁମୋଦନ ମିଳେ, ତାହାହେଲେ ଭାରତରେ ଏହି ଟିକା ୨୦୨୧ ଫେବ୍ରୁଆରୀ ସୁଦ୍ଧା ସ୍ୱାସ୍ଥ୍ୟକର୍ମୀ ଓ ବୟସ୍କ…

Bhubaneswar: Chief Minister Naveen Patnaik today said that people above sixty and pregnant mothers will get priority in COVID-19 vaccine distribution along with health workers in Odisha. The Chief Minister made this big announcement at a…

Cambridge: The US-based biotechnology company Moderna today said that its vaccine candidate was 94.5 per cent effective in preventing Covid-19 based on interim data from a late-stage clinical trial. The independent, NIH-appointed Data…

1. About 20 COVID-19 vaccines in different stages of developments in India: Vardhan 2. Kerala starts uploading data for Covid-19 vaccine shots 3. India may get 100 million doses of AstraZeneca's COVID-19 vaccine by Dec 2020 4. US aims to…

New Delhi: Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, and Indian Council of Medical Research (ICMR), the apex body in India for biomedical research, announced completion of enrolment of phase 3…

New York: Pfizer Inc and BioNTech SE yoday announced their mRNA based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of SARS-CoV-2 infection,…